Access to credible information on schizophrenia patients’ medication adherence by prescribers can change their treatment strategies: evidence from an online survey of providers

References

• HaddadPMBrainCScottJNonadherence with antipsychotic medication in schizophrenia: challenges and management strategiesPatient Relat Outcome Meas20145436225061342
   PubMedGoogle Scholar
• NovickDHaroJMSuarezDPerezVDittmannRWHaddadPMPredictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophreniaPsychiatry Res20101762–310911320185182
   PubMed Web of Science ®Google Scholar
• Ascher-SvanumHFariesDEZhuBErnstFRSwartzMSSwansonJWMedication adherence and long-term functional outcomes in the treatment of schizophrenia in usual careJ Clin Psychiatry200667345346016649833
   PubMed Web of Science ®Google Scholar
• LindenmayerJPLiu-SeifertHKulkarniPMMedication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior responseJ Clin Psychiatry200970799099619497244
   PubMed Web of Science ®Google Scholar
• SubotnikKLNuechterleinKHVenturaJRisperidone nonadherence and return of positive symptoms in the early course of schizophreniaAm J Psychiatry2011168328629221205805
   PubMed Web of Science ®Google Scholar
• BayleFJTessierABoujuSMisdrahiDMedication adherence in patients with psychotic disorders: an observational survey involving patients before they switch to long-acting injectable risperidonePatient Prefer Adherence201591333134126396505
   PubMed Web of Science ®Google Scholar
• OffordSLinJMirskiDWongBImpact of early nonadherence to oral antipsychotics on clinical and economic outcomes among patients with schizophreniaAdv Ther201330328629723483449
   PubMed Web of Science ®Google Scholar
• SajatovicMVelliganDIWeidenPJValensteinMAOgedegbeGMeasurement of psychiatric treatment adherenceJ Psychosom Res201069659159921109048
   PubMed Web of Science ®Google Scholar
• VelliganDIWangMDiamondPRelationships among subjective and objective measures of adherence to oral antipsychotic medicationsPsychiatr Serv20075891187119217766564
   PubMed Web of Science ®Google Scholar
• ByerlyMJThompsonACarmodyTValidity of electronically monitored medication adherence and conventional adherence measures in schizophreniaPsychiatr Serv200758684484717535946
   PubMed Web of Science ®Google Scholar
• StephensonJJTunceliOGuTAdherence to oral second-generation antipsychotic medications in patients with schizophrenia and bipolar disorder: physicians’ perceptions of adherence vs. pharmacy claimsInt J Clin Pract201266656557322574724
   PubMed Web of Science ®Google Scholar
• GarfeinRSCollinsKMunozFFeasibility of tuberculosis treatment monitoring by video directly observed therapy: a binational pilot studyInt J Tuberc Lung Dis20151991057106426260824
   PubMed Web of Science ®Google Scholar
• ProfitDRohatagiSZhaoCHatchADochertyJPPeters-StricklandTSDeveloping a digital medicine system in psychiatry: ingestion detection rate and latency periodJ Clin Psychiatry2016779e1095e110027379966
   PubMed Web of Science ®Google Scholar
• RohatagiSProfitDHatchAZhaoCDochertyJPPeters-StricklandTSOptimization of a digital medicine system in psychiatryJ Clin Psychiatry2016779e1101e110727487251
   PubMed Web of Science ®Google Scholar
• KulkarniJReeve-ParkerKPsychiatrists’ awareness of partial- and non-adherence to antipsychotic medication in schizophrenia: results from the Australian ADHES surveyAustralas Psychiatry201523325826425783668
   PubMed Web of Science ®Google Scholar
• GeertsPMartinezGSchreinerAAttitudes towards the administration of long-acting antipsychotics: a survey of physicians and nursesBMC Psychiatry2013135823414331
   PubMed Web of Science ®Google Scholar
• TangYChangCCLaveJRGelladWFHuskampHADonohueJMPatient, physician and organizational influences on variation in antipsychotic prescribing behaviorJ Ment Health Policy Econ2016191455927084793
   PubMed Web of Science ®Google Scholar
• MarkTLKassedCAVandivort-WarrenRLevitKRKranzlerHRAlcohol and opioid dependence medications: prescription trends, overall and by physician specialtyDrug Alcohol Depend2009991–334534918819759
   PubMed Web of Science ®Google Scholar
• BrissosSVeguillaMRTaylorDBalanza-MartinezVThe role of long-acting injectable antipsychotics in schizophrenia: a critical appraisalTher Adv Psychopharmacol20144519821925360245
   PubMedGoogle Scholar
• LopezLVKaneJMPlasma levels of second-generation antipsychotics and clinical response in acute psychosis: a review of the literatureSchizophr Res20131472–336837423664462
   PubMed Web of Science ®Google Scholar
• LopezLVKaneJMRecommendations for the monitoring of serum concentrations of antipsychotic drugs in the treatment of schizophreniaJ Clin Psychiatry20157691249125026455671
   PubMed Web of Science ®Google Scholar
• GrundmannMKacirovaIUrinovskaRTherapeutic drug monitoring of atypical antipsychotic drugsActa Pharm201464438740125531781
   PubMed Web of Science ®Google Scholar
• VelliganDILamYWGlahnDCDefining and assessing adherence to oral antipsychotics: a review of the literatureSchizophr Bull200632472474216707778
   PubMed Web of Science ®Google Scholar
• FranzMRangerJHanewaldBGallhoferBLayBInfluences on therapist’s decisions for neuroleptic treatment in schizophrenia: the role of characteristics of the patient and the physicianPharmacopsychiatry201245726126822648306
   PubMed Web of Science ®Google Scholar
• VelliganDIWeidenPJSajatovicMThe expert consensus guideline series: adherence problems in patients with serious and persistent mental illnessJ Clin Psychiatry200970Suppl 4146 quiz 47–4819686636
   PubMed Web of Science ®Google Scholar
• Peters-StricklandTPestreichLHatchAUsability of a novel digital medicine system in adults with schizophrenia treated with sensor-embedded tablets of aripiprazoleNeuropsychiatr Dis Treat2016122587259427785036
   PubMed Web of Science ®Google Scholar
• LafeuilleMHGravelJLefebvrePPatterns of relapse and associated cost burden in schizophrenia patients receiving atypical antipsychoticsJ Med Econ201316111290129924006903
   PubMedGoogle Scholar
• ShafrinJSchwartzTTLakdawallaDNFormaFMEstimating the value of new technologies that provide more accurate drug adherence information to providers for their patients with schizophreniaJ Manag Care Spec Pharm201622111285129127783545
   PubMed Web of Science ®Google Scholar